Comparison between a novel sirolimus-eluting bioresorbable scaffold with everolimus-eluting metallic stent in patients with coronary artery disease: three-year follow-up from the neovas rct study

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Interventional Cardiology ePosters Devices ESC Premium Access ESC Congress 2021 - The Digital Experience